Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

by Katelyn D. Bothwell, Margaret Folaron, Mukund Seshadri
Published 2016-01-01

Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response

by Margaret Folaron, Mihai Merzianu, Umamaheswar Duvvuri, Robert L. Ferris, Mukund Seshadri
Published 2019-07-01